Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study.
Sign Up to like & getrecommendations! Published in 2020 at "Antiviral research"
DOI: 10.1016/j.antiviral.2020.104763
Abstract: Influenza A infections cause significant seasonal morbidity and mortality as well as periodic pandemic infections. Currently, no approved therapies exist for patients hospitalized with influenza. The efficacy of VIS410, a broadly neutralizing human immunoglobulin IgG1… read more here.
Keywords: treatment; clinical virological; virological responses; vis410 ... See more keywords